Fingerprint
Dive into the research topics of 'New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer
Robert C. Doebele, Ana B. Oton, Nir Peled, D. Ross Camidge, Paul A. Bunn
Research output: Contribution to journal › Review article › peer-review
52
Scopus
citations